SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-087437
Filing Date
2021-06-30
Accepted
2021-06-30 14:26:38
Documents
1
Group Members
AH BIO FUND II-B, L.P.AH EQUITY PARTNERS BIO II, L.L.C.AH EQUITY PARTNERS LSV II, L.L.C.ANDREESSEN HOROWITZ LSV FUND II, L.P.ANDREESSEN HOROWITZ LSV FUND II-B, L.P.ANDREESSEN HOROWITZ LSV FUND II-Q, L.P.BENJAMIN HOROWITZMARC ANDREESSEN

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2121035d1_sc13d.htm SC 13D 205547
  Complete submission text file 0001104659-21-087437.txt   207475
Mailing Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025
Business Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025 650-798-3900
AH Bio Fund II, L.P. (Filed by) CIK: 0001725721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Subject) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91615 | Film No.: 211061504
SIC: 6770 Blank Checks